You are here
- Home
- Therapy Areas
Gastrointestinal
The following trials provide information to treat various types of gastrointestinal diseases, both for ongoing and completed clinical trials. For more information on this therapy area please click here.
- collapse Nexium capsules Clinical Experience Investigation
- collapse Drug utilization and safety events among children using esomeprazole, other proton pump inhibitors or H2-receptor antagonists
- collapse Nexium capsules Hp Specific Clinical Experience Investigation
- collapse European Real Life Study on NSAIDs Treated Patients With Osteoarthritis (OA), Rheumatoid Arthritis (RA) and Ankylosing Spondylitis (AS): Assessment of Pain Relieve, Gastrointestinal (GI) Symptoms, Adherence and Health Resource Consumption
-
expand
Study of Incidence of Drug-induced Upper Gastrointestinal Bleeding
- Study Id
- NIS-GRU-NEX-2009/2
- Disease
- gastrointestinal bleeding
- Drug Name
- Nexium
- Study Name
- NIS-GRU-NEX-2009/2
- Recruiting Status
- Open
- Protocol Status
- Not Available
- Report
-
Feb 24, 2012
- NIS-GRU-NEX-2009_2.pdf (405 KB)
- collapse A multicentre, double-blind, randomised, parallel-group, Phase III study to assess efficacy and safety of D9421-C 9 mg versus Mesalazine 3 g in patients with active Crohn’s Disease (CD) in Japan
- collapse National Survey on GERD Patients (Adults and Children)
- collapse Survey of Non-Variceal Upper Gastro Intestinal Bleeding in Vietnamese Patients
- collapse A randomized, double-blind, placebo controlled, study to evaluate the efficacy and safety of esomeprazole once daily for the treatment of gastroesophageal reflux disease (GERD) in neonatal patients, including premature and up to 1 month corrected age
- collapse Recurrence Rate, Risk Factors for the Recurrence, and Quality of Life in Patients With GERD in Korea-an Observational
